Conjugated estrogens/Medroxyprogesterone acetate

结合雌激素/醋酸甲羟孕酮

Report date: 2024/02/21 14:41:04

Base Information

Drug NameConjugated estrogens/Medroxyprogesterone acetate
Drug Alias NameMedroxyprogesterone Acetate/Conjugated Estrogens醋酸甲羟孕酮/结合雌激素Premarin/medroxyprogesterone acetatePremphasePrempro
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor agonistsEstrogen receptors agonists
TargetsEstrogen receptorsProgesterone receptor
Therapy Area/IndicationsVasomotor symptomVulvar and vaginal atrophyMenopausal symptoms +[7] 
Global Approved IndicationsVasomotor symptomVulvar and vaginal atrophyOsteoporosis, Postmenopausal
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1995/11/17
Country/TerritoryUnited States
CombinationsYes Medroxyprogesterone AcetateConjugated Estrogens
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesWyeth Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWyeth-AyerstWyeth Pharmaceuticals Inc
Inactive CompaniesNational Institute Of Neurological Disorders And Stroke
Active IndicationsVasomotor symptomVulvar and vaginal atrophyAtrophy +[5] 
Inactive IndicationsMenopausal symptomsEpilepsy

Other Information

ATC CodeG03AA08G03AA17
Related LinksWikipedia